European Foundation for the Study of Diabetes (EFSD)



European Diabetes Research Programme in Macrovascular Complications

Request for Applications

Deadline for submission of applications: 15 March 2017



The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide multiple funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi Diabetes and Cardiovascular is dedicated to delivering innovative, value-based medicines and integrated solutions. Sanofi is committed to a collaborative approach that involves strategic alliances with professional and patient associations, research institutions and leaders in healthcare and other industries, with the goal of advancing scientific knowledge, driving the convergence of science and technology, helping to improve outcomes and inspiring and evolution in care.

Programme Research and Focus

EFSD and Sanofi have established a new programme called the EFSD/Sanofi European Diabetes Research Programme in Macrovascular Complications to encourage new projects aimed at advancing current knowledge in this field.  To achieve the goals and objectives of this Programme, EFSD and Sanofi invite applications by issuring this "Request for Applications" (RFA) which indicates joint funding as well as areas of research emphasis.  The EFSD/Sanofi European Diabetes Research Programme is intended to stimulate and accelerate European research on macrovascular complications.  Grants are offered for basic or clinical mechanistic studies. For the former, innovative studies including use of advance stem cell approaches will be particularly welcome, whereas studies involving classical animal models of macrovascular disease will not be considered for funding.

Mechanism of Support and Review

Research will be supported through the award of grants, each of up to Euro 100,000  for basic projects and Euro 250,000 for clinical projects. The duration of each award may be one year or longer, depending upon the needs of the project and as justified in the application. EFSD may, on advisement from the Review Committee, recommend an award in a different amount than requested but which is  considered more appropriate for the proposed studies.

Applicants who have a funding requirement larger than that specified above are also invited to apply to this Programme, particularly if this relates to a clinical research project: in this case, the relevant financial requirement should be well justified in the budget section of the application form for special consideration by the review committee.

Studies forming part of a larger project will be considered for funding, but this will need to be well justified in the application (see Review Considerations).

Applications for an EFSD/Sanofi grant are invited from single non-profit institutions or groups of such institutions from Europe or associated countries. The principal investigator and any co-investigators must be normally employed at a non-profit institution and the study must be performed at their place of work.  

Applications will be subject to scientific review by a specialised ad hoc committee. It is anticipated that applications will be received, reviewed and the successful project approved for funding by June/July 2017.

Prior to any final decision on funding, and in order to offer applicants the opportunity to benefit from the review process, EFSD reserves the right to request revision to applications in accordance with the recommendations of the Review Committee.

Research Grant Applications

Applications for research grants may be subjected to pre-review (or triage) procedures. In this event, any application rejected at pre-review will not be subject to a complete scientific review and no feedback report will be provided to the applicant. The deadline for receipt of research grant applications for funding this year is 15 March 2017.

All budgets are to be prepared in Euro. For countries in which the Euro is not yet the common currency, the exchange rate (between the Euro and the local currency in the country where the work is to be performed) used for calculating the Euro budget must be mentioned under "Budget Justification".

Application forms may be downloaded here

All applications must be prepared on the official forms and completed in strict accordance with the detailed instructions to be found on these forms. Applications which do not comply with the instructions given in the application form will not be considered for review.

Please send your application as one complete PDF email attachment to the following address before 12:00 midday (CET) on the deadline date: This email address is being protected from spambots. You need JavaScript enabled to view it.

Review Considerations

Completed applications will be evaluated in accordance with the criteria stated below for scientific/technical merit by an appropriate scientific committee.

Review criteria are as follows:

  • Significance: Does the study address an important problem in keeping with the goals and focus areas of this Programme? If the aims of the application are achieved, how will scientific knowledge be advanced? What will be the effect of the proposed studies on the concepts or methods that drive this field?
  • Approach: Are the conceptual framework, design, methods and analyses adequately developed, well integrated, and appropriate to the aims of the project? Are they supported by preliminary data? Does the applicant acknowledge potential problem areas and consider alternative tactics?
  • Innovation: Does the project employ novel concepts, approaches or methods? Are the aims original and innovative? Does the project challenge existing paradigms or develop new methodologies or technologies?
  • Investigator: Is the investigator appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the principal investigator and other researchers, if any?
  • Environment: Does the scientific environment in which the work will be carried out contribute to the probability of success? Do the proposed experiments take advantage of unique features of the scientific environment or employ useful collaborative arrangements? Is there evidence of institutional support?
  • Budget and feasibility: Is the budget appropriate for the proposed study? Is the requested duration suitable for completion of the project?
  • Contribution towards a larger research project: Is the work described in the application intended as part of a larger project? If so, is there any overlap? Is there a clear explanation how the new work will contribute towards the overall success of the larger project?

Reporting Requirements and Approval of Funding 

All investigators funded by this Programme are required to submit a scientific progress report at the end of the project period. For those projects where funding is distributed over a period of more than one year, interim progress reports will also be required. Such reports will be subject to assessment prior to the release of any further funds.

Investigators must provide EFSD with copies of papers accepted for publication, and must acknowledge the support of the Programme in all written material by use of the phrase: "supported by an EFSD/Sanofi research grant".

Competitive Renewal

Applications for a grant renewal grant will be accepted on a competitive basis, with the same review process as described in this Announcement. Such applications will thus be considered in the same fashion as all other new applications received for review and without any special priority.



December 2016

Application Deadline:

15 March 2017

Anticipated Award:

June/July 2017

Enquiries should be directed to:

European Foundation for the Study of Diabetes
Rheindorfer Weg 3
40591 DĂĽsseldorf, Germany
Tel: +49-211-75 84 69 0
Fax: + 49-211-75 84 69 29
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.